Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates
Go back to Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates| (NASDAQ: MDGL) | Delayed: 542.75 +8.59 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $534.16 | 52 Week High | $18.24 | |||
| Open | $529.50 | 52 Week Low | $6.60 | |||
| Day High | $546.88 | P/E | N/A | |||
| Day Low | $526.88 | EPS | $0.00 | |||
| Volume | 170,546 | |||||

